We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Therapeutic Effect of Clopidogrel on Cutaneous Polyarteritis Nodosa

Tamihiro Kawakami, MD, PhD; Yoshinao Soma, MD, PhD
Arch Dermatol. 2010;146(1):100-101. doi:10.1001/archdermatol.2009.349.
Text Size: A A A
Published online


Clopidogrel is a drug in the recently developed class of thienopyridine derivatives used to block adenosine diphosphate receptors on platelets, a blockade that results in the inhibition of platelet aggregation.1 The current use of clopidogrel is mainly to prevent stent restenosis in coronary artery disease and in the early and long-term prevention of atherothrombotic events.

Rousseau  PTartas  MFromy  B  et al.  Platelet inhibition by low-dose aspirin but not by clopidogrel reduces the axon-reflex current-induced vasodilation in humans. Am J Physiol Regul Integr Comp Physiol 2008;294 (5) R1420- R1426
PubMed Link to Article[[XSLOpenURL/10.1152/ajpregu.00810.2007]]
Kawakami  TYamazaki  MMizoguchi  MSoma  Y High titer of anti-phosphatidylserine–prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Arthritis Rheum 2007;57 (8) 1507- 1513
PubMed Link to Article[[XSLOpenURL/10.1002/(ISSN)1529-0131]]
Maree  AOFitzgerald  DJ Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007;115 (16) 2196- 2207
PubMed Link to Article[[XSLOpenURL/10.1161/CIRCULATIONAHA.106.675991]]
Heitzer  TRudolph  VSchwedhelm  E  et al.  Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 2006;26 (7) 1648- 1652
PubMed Link to Article[[XSLOpenURL/10.1161/01.ATV.0000225288.74170.dc]]
Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1

In case 1, infiltration of the arterial wall predominantly by neutrophils induced destructive and occlusive changes in the subcutaneous fat. Fibrinoid degeneration was also seen (hematoxylin-eosin, original magnification ×20).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2

In case 2, examination revealed erythematous macules, purpuric lesions, and nodules scattered over the extremities.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

2 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles